Rapid Micro Biosystems, Inc. (RPID)

NASDAQ: RPID · IEX Real-Time Price · USD
+0.045 (4.73%)
Feb 23, 2024, 4:00 PM EST - Market closed

Company Description

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, and internationally.

The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services.

Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables.

The company also provides installation and verification, onsite technical training, and customer support services.

Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications.

In addition, it offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; and RMBNucleus Central Manager portal streamlines monitoring and reporting.

The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007.

Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems logo
Country United States
Founded 2006
IPO Date Jul 15, 2021
Industry Medical Devices
Sector Healthcare
Employees 177
CEO Robert G. Spignesi Jr.

Contact Details

1001 Pawtucket Blvd.
Lowell, Massachusetts 01854
United States
Phone 978-349-3200
Website rapidmicrobio.com

Stock Details

Ticker Symbol RPID
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $20.00
CIK Code 0001380106
CUSIP Number 75340L104
ISIN Number US75340L1044
SIC Code 3826

Key Executives

Name Position
Robert G. Spignesi Jr. Chief Executive Officer, President and Director
Sean M. Wirtjes Chief Financial Officer
John J. Addington Wilson Chief Operating Officer
Michael Beaulieu C.F.A. Vice President of Investor Relations and Corporate Communications
Michael Wysocki Senior Vice President of Sales and Marketing
Victoria L. Vezina Chief Human Resources Officer
Kristine Williams Senior Vice President of Research and Development and Product Management

Latest SEC Filings

Date Type Title
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 2, 2024 8-K Current Report
Jan 22, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2024 8-K Current Report
Dec 28, 2023 424B3 Prospectus
Dec 26, 2023 EFFECT Notice of Effectiveness
Dec 15, 2023 S-3 Registration statement under Securities Act of 1933
Nov 3, 2023 10-Q Quarterly Report
Nov 3, 2023 8-K Current Report
Sep 26, 2023 8-K Current Report